TY - JOUR
T1 - The effect of combination therapy with interferon and cryofiltration on mesangial proliferative glomerulonephritis originating from mixed cryoglobulinemia in chronic hepatitis C virus infection
AU - Kiyomoto, Hideyasu
AU - Hitomi, Hirofumi
AU - Hosotani, Youko
AU - Hashimoto, Mayuko
AU - Uchida, Kouichi
AU - Kurokouchi, Kazutaka
AU - Nagai, Masami
AU - Takahashi, Norihiro
AU - Fukunaga, Megumu
AU - Mizushige, Katsufumi
AU - Matsuo, Horohide
AU - Yuasa, Shigekazu
PY - 1999/12/17
Y1 - 1999/12/17
N2 - Cryofiltration, which has developed from double filtration plasmapheresis (DFPP) with a cooling unit, is an on-line technique to remove cryoglobulin. We report on a patient who suffered from progressive edema and renal insufficiency caused by cryoglobulinemic membranoproliferative glomerulonephritis (MPGN), probably due to chronic hepatitis C virus (HCV) infection. To remove cryoglobulins and terminate the HCV infection, we utilized combination therapy with cryofiltration and interferon-α injection with corticosteroids. Interferon-α was capable of decreasing proteinuria but not diminishing cryoglobulin. Additional cryofiltration could remove cryoglobulin to an undetectable level. This combination therapy was partially successful to reduce proteinuria and prevent the progressive deterioration of renal function. The major adverse effects of this therapy were bleeding and myelosuppression. We conclude that this combination therapy may be effective and should be considered as treatment for cryoglobulinemic MPGN.
AB - Cryofiltration, which has developed from double filtration plasmapheresis (DFPP) with a cooling unit, is an on-line technique to remove cryoglobulin. We report on a patient who suffered from progressive edema and renal insufficiency caused by cryoglobulinemic membranoproliferative glomerulonephritis (MPGN), probably due to chronic hepatitis C virus (HCV) infection. To remove cryoglobulins and terminate the HCV infection, we utilized combination therapy with cryofiltration and interferon-α injection with corticosteroids. Interferon-α was capable of decreasing proteinuria but not diminishing cryoglobulin. Additional cryofiltration could remove cryoglobulin to an undetectable level. This combination therapy was partially successful to reduce proteinuria and prevent the progressive deterioration of renal function. The major adverse effects of this therapy were bleeding and myelosuppression. We conclude that this combination therapy may be effective and should be considered as treatment for cryoglobulinemic MPGN.
KW - Cryofiltration
KW - Cryoglobulin
KW - Hepatitis C virus
KW - Interferon
KW - Membranoproliferative glomerulonephritis
UR - http://www.scopus.com/inward/record.url?scp=6544243438&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=6544243438&partnerID=8YFLogxK
U2 - 10.1046/j.1526-0968.1999.00196.x
DO - 10.1046/j.1526-0968.1999.00196.x
M3 - Article
C2 - 10608730
AN - SCOPUS:6544243438
SN - 1744-9979
VL - 3
SP - 329
EP - 333
JO - Therapeutic Apheresis and Dialysis
JF - Therapeutic Apheresis and Dialysis
IS - 4
ER -